425: Strive & Semler Scientific Advance Merger Plans

Strive, Inc. and Semler Scientific, Inc. are progressing with their proposed business combination, as publicly communicated by Strive's CEO.

Summary

• Strive, Inc. and Semler Scientific, Inc. are pursuing a proposed business combination.
• The communication regarding this transaction was reposted on X.com by Matthew Cole, Chief Executive Officer of Strive, Inc., on September 25, 2025.
• The proposed transaction is expected to bring strategic and financial benefits and impact the combined company's future financial performance.
• Strive intends to file a Registration Statement on Form S-4 with the SEC to register Class A common stock to be issued in connection with the merger.
• The Form S-4 will include an Information Statement/Proxy Statement/Prospectus for Semler Scientific stockholders to approve the transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available for important information.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While the filing announces a significant corporate action (merger) with anticipated benefits, it also includes an extensive and detailed list of risks and uncertainties, balancing any immediate positive outlook. No specific financial results or definitive positive outcomes are presented, only forward-looking statements and procedural information.

Positives

• The proposed transaction is anticipated to yield strategic benefits for the combined company.
• The proposed transaction is anticipated to yield financial benefits for the combined company.
• The transaction is expected to positively impact the combined company's future financial performance.

Negatives

• The integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated.
• Management's attention may be diverted from ongoing business operations and opportunities due to the transaction.
• Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction will cause dilution for existing shareholders.
• There is a risk of potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price may occur before the closing of the transaction.

Risks

• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including anticipated cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact the transaction.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.

Future Outlook

The companies anticipate strategic and financial benefits from the proposed transaction, expecting a positive impact on the combined company's future financial performance and successful integration. However, these are forward-looking statements subject to various risks and uncertainties, including the timing of closing and the realization of anticipated benefits.

Management Comments

• Matthew Cole, Chief Executive Officer of Strive, Inc., reposted the communication on X.com on September 25, 2025, regarding the proposed business combination with Semler Scientific, Inc.

Industry Context

The filing's mention of risks associated with 'Bitcoin treasury strategies and other digital assets' highlights a growing trend among companies, including Semler Scientific, to incorporate digital assets into their corporate treasury strategies. This indicates a broader industry movement towards digital asset adoption and the associated regulatory and market risks.

Stakeholder Impact

• Shareholders of Strive will experience dilution due to the issuance of additional Class A common stock.
• Customers of both Strive and Semler Scientific may have adverse reactions to the proposed transaction.
• Employee relationships at both companies could change as a result of the announcement or completion of the merger.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC.
• The Registration Statement will include an Information Statement/Proxy Statement/Prospectus.
• Semler Scientific stockholders will be sent a definitive Information Statement/Proxy Statement/Prospectus to seek their approval of the proposed transaction.

Key Dates

Keywords

Strive Inc., Semler Scientific Inc., Merger, Business Combination, SEC Filing, Form 425, Bitcoin Treasury, Digital Assets, Corporate Governance, Financial Reporting